Page last updated: 2024-08-20

2-chloroadenosine and Cardiometabolic Syndrome

2-chloroadenosine has been researched along with Cardiometabolic Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asano, S; Bender, SB; Borbouse, L; Bratz, IN; Dick, GM; Dincer, UD; Neeb, ZP; Payne, GA; Sturek, M; Tune, JD	1
Hashimoto, M; Kagota, S; Kubota, Y; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tanaka, N; Yamamoto, R	1

Other Studies

2 other study(ies) available for 2-chloroadenosine and Cardiometabolic Syndrome

Article	Year
Impaired function of coronary BK(Ca) channels in metabolic syndrome. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:5 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 2-Chloroadenosine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arterioles; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Coronary Circulation; Coronary Vessels; Diet, Atherogenic; Disease Models, Animal; Dose-Response Relationship, Drug; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Large-Conductance Calcium-Activated Potassium Channel beta Subunits; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Metabolic Syndrome; Microcirculation; Muscle, Smooth, Vascular; Mycotoxins; Nicardipine; Peptides; Phenotype; Potassium Channel Blockers; Swine; Swine, Miniature; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	2009
Dysfunction of purinergic regulation of sympathetic neurotransmission in SHR/NDmcr-cp (SHR-cp) rat. Clinical and experimental pharmacology & physiology, 2004, Volume: 31 Suppl 2 Topics: 2-Chloroadenosine; Adenosine Triphosphate; Animals; Arteries; Electric Stimulation; In Vitro Techniques; Male; Metabolic Syndrome; Norepinephrine; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Purinergic P1; Receptors, Purinergic P2; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction	2004

Article

Year

Impaired function of coronary BK(Ca) channels in metabolic syndrome.

American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:5

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 2-Chloroadenosine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arterioles; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Coronary Circulation; Coronary Vessels; Diet, Atherogenic; Disease Models, Animal; Dose-Response Relationship, Drug; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Large-Conductance Calcium-Activated Potassium Channel beta Subunits; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Metabolic Syndrome; Microcirculation; Muscle, Smooth, Vascular; Mycotoxins; Nicardipine; Peptides; Phenotype; Potassium Channel Blockers; Swine; Swine, Miniature; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2009

Dysfunction of purinergic regulation of sympathetic neurotransmission in SHR/NDmcr-cp (SHR-cp) rat.

Clinical and experimental pharmacology & physiology, 2004, Volume: 31 Suppl 2

Topics: 2-Chloroadenosine; Adenosine Triphosphate; Animals; Arteries; Electric Stimulation; In Vitro Techniques; Male; Metabolic Syndrome; Norepinephrine; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Purinergic P1; Receptors, Purinergic P2; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction

2004